Open access
Aug 2026
NF-κB/Lipocalin 2 Signaling Pathway Mitigates the Chemoresistance of BRAFV600E-Mutant Colorectal Cancer to Cisplatin by Promoting Ferroptosis
A key role is found for NF-κB/Lipocalin 2 (LCN2)-signaling-pathway-induced ferroptosis in modulating cisplatin sensitivity of V600E-overexpressing CRC cells to cisplatin within a KRAS-mutant cellular background, implying LCN2 as a potential therapeutic target.
M. Feng, Xuesong Wu, Li Jiang et al.
· Cancers · 0 citations